pSIREN-RetroQ-CDK6-shRNA Citations (1)

Originally described in: miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, Lieberman J Blood. 2009 Sep 3. 114(10):2181-92. PubMed Journal

---

Articles Citing pSIREN-RetroQ-CDK6-shRNA

Articles
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence. Yang C, Li Z, Bhatt T, Dickler M, Giri D, Scaltriti M, Baselga J, Rosen N, Chandarlapaty S. Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.379. PubMed

If you have published an article using this material, please email us at to have your article added to this page.